Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.005 USD | +5.53% | +4.97% | -32.94% |
03-25 | Esperion Shares Continue Rise After Friday's FDA Approval for Nexlizet, Nexletol | DJ |
03-25 | Sector Update: Health Care Stocks Steady Premarket Monday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.94% | 360M | |
+26.24% | 661B | |
+26.74% | 566B | |
-6.37% | 352B | |
+19.16% | 332B | |
+3.97% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.10% | 145B |
- Stock Market
- Equities
- ESPR Stock
- News Esperion Therapeutics, Inc.
- Esperion Therapeutics's Shares Decline Around Midday After Pricing $225 Million Offering